These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24948569)

  • 21. Why the Authors Use Cardiac Resynchronization Therapy with Defibrillators.
    Sze E; Daubert JP
    Card Electrophysiol Clin; 2015 Dec; 7(4):695-707. PubMed ID: 26596812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
    Chia PL; Foo D
    Singapore Med J; 2016 Jul; 57(7):354-9. PubMed ID: 27440409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
    Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
    Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients.
    Farmer SA; Tuohy EJ; Small DS; Wang Y; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):798-807. PubMed ID: 23093561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival with cardiac-resynchronization therapy in mild heart failure.
    Goldenberg I; Kutyifa V; Klein HU; Cannom DS; Brown MW; Dan A; Daubert JP; Estes NA; Foster E; Greenberg H; Kautzner J; Klempfner R; Kuniss M; Merkely B; Pfeffer MA; Quesada A; Viskin S; McNitt S; Polonsky B; Ghanem A; Solomon SD; Wilber D; Zareba W; Moss AJ
    N Engl J Med; 2014 May; 370(18):1694-701. PubMed ID: 24678999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More.
    Daubert JC; Martins R; Leclercq C
    Card Electrophysiol Clin; 2015 Dec; 7(4):709-20. PubMed ID: 26596813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis.
    Stavrakis S; Lazzara R; Thadani U
    J Cardiovasc Electrophysiol; 2012 Feb; 23(2):163-8. PubMed ID: 21815961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter defibrillators and cardiac resynchronisation therapy.
    Holzmeister J; Leclercq C
    Lancet; 2011 Aug; 378(9792):722-30. PubMed ID: 21856486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures.
    Hauptman PJ; Swindle JP; Masoudi FA; Burroughs TE
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):204-11. PubMed ID: 20197509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization therapy: implant rates, temporal trends and relationships with heart failure epidemiology.
    Boriani G; Berti E; Belotti LM; Biffi M; Carboni A; Bandini A; Casali E; Tomasi C; Toselli T; Baraldi P; Bottoni N; Barbato G; Sassone B;
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):147-54. PubMed ID: 23811841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal utilization and management of implanted cardiac rhythm devices in patients hospitalized for heart failure.
    Randolph T; Piccini JP
    Heart Fail Clin; 2013 Jul; 9(3):321-30, vi. PubMed ID: 23809418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whom should I refer in 2014 for cardiac resynchronization?
    Manlucu J; Tang AS
    Can J Cardiol; 2014 Jun; 30(6):675-8. PubMed ID: 24882541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.